Revisiting the dynamic risks of incident atrial fibrillation: does the use of nonsteroidal anti-inflammatory drugs contribute to risk?
QJM
.
2020 Feb 1;113(2):77-78.
doi: 10.1093/qjmed/hcz310.
Authors
Stephanie L Harrison
1
,
Martin O'Flaherty
2
,
Gregory Y H Lip
1
3
Affiliations
1
From the Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
2
Department of Public Health and Policy, University of Liverpool, Liverpool, UK.
3
Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
PMID:
31769849
DOI:
10.1093/qjmed/hcz310
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal
Atrial Fibrillation*
Humans
Incidence
Risk Assessment
Substances
Anti-Inflammatory Agents, Non-Steroidal